Jefferies analyst Glen Santangelo lowered the price target on Hims and Hers (NYSE: HIMS) to $48.00 (from $51.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst PT Change Hot Comments

Hims and Hers (HIMS) PT Raised to $46 at Leerink PartnersNovember 4, 2025 6:22 AM KeyBanc: 'Hims and Hers (HIMS) Setting the Stage for Future Growth'November 4, 2025 6:06 AM Needham on Hims and Hers (HIMS): 'we believe this incremental near-term investment and likely growing pains'November 4, 2025 5:13 AM Hims and Hers (HIMS) PT Raised to $32 at BofA SecuritiesNovember 4, 2025 5:10 AM BTIG Hims and Hers (HIMS): 'MAHA is being Implemented through HIMS with Proactive Health'November 4, 2025 4:35 AM Canaccord Genuity Reiterates Buy Rating on Hims and Hers (HIMS)November 4, 2025 3:20 AM After-hours movers: Palantir, Hims & Hers Health, Sarepta Therapeutics, Sanmina November 3, 2025 4:41 PM Hims and Hers tops revenue estimates as telehealth provider attracts more usersNovember 3, 2025 4:19 PM Form 10-Q Hims & Hers Health, Inc. For: Sep 30November 3, 2025 4:17 PM Hims & Hers in talks with Novo Nordisk to offer Wegovy treatmentsNovember 3, 2025 4:10 PM Hims & Hers Health, Inc. (HIMS) Misses Q3 EPS by 4c, Offers GuidanceNovember 3, 2025 4:09 PM Form 8-K Hims & Hers Health, Inc. For: Nov 03November 3, 2025 4:09 PM Hims & Hers Health, Inc. Reports Third Quarter 2025 Financial ResultsNovember 3, 2025 4:05 PM Hims & Hers Health, Inc. (HIMS) call put ratio 1.4 calls to 1 put into quarter results November 3, 2025 10:17 AM Hims & Hers Health, Inc. (HIMS) call put ratio 1.4 calls to 1 put into quarter results October 31, 2025 10:29 AM Form SCHEDULE 13G Hims & Hers Health, Inc. Filed by: JPMORGAN CHASE & COOctober 31, 2025 9:49 AM